Effects of brief and intermediate exposures to sulfate submicron aerosols and sulfate injections and cardiopulmonary function of dogs and tracheal mucous velocity of sheep. 1981

M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck

Pulmonary mechanics of anesthetized dogs were not changed or were minimally altered by breathing the following compounds as submicron aerosols in concentrations up to 17.3 mg/m3 for 7.5 min: (1) sodium chloride (as a control), (2) sodium sulfate, (3) ammonium sulfate, (4) zinc sulfate, (5) zinc ammonium sulfate, (6) ammonium bisulfate, (7) aluminum sulfate, (8) manganese sulfate, (9) nickel sulfate, (10) copper sulfate, (11) ferrous sulfate, and (12) ferric sulfate. Submicron aerosols of these compounds in concentrations of 4.1-8.8 mg/m3, administered for 4 h to anesthetized dogs, did not affect mechanics of breathing, hemodynamics, and arterial blood gases. In conscious sheep, tracheal mucous velocity was not altered by exposure to the submicron aerosols of the sulfate compounds. None of these compounds, injected iv in a dose of 1 mg, had adverse effects on mechanics of breathing, pulmonary and systemic hemodynamics, or arterial blood gases. In 100-mg injections, zinc sulfate and zinc ammonium sulfate produced a fall in cardiac output, systemic hypotension, hypoxemia, and metabolic acidosis. Copper sulfate at this dose produced pulmonary hypertension, a fall in cardiac output, hypoxemia, respiratory acidosis, and a decrease of specific total respiratory conductance. It is concluded that submicron aerosols of sulfate salts do not have adverse cardiopulmonary effects when administered in high concentrations for up to 4 h. However, prolonged exposure to high concentrations of zinc sulfate, zinc ammonium sulfate, and copper sulfate aerosols should be carefully monitored because of the possibility that lower levels of these compounds in the bloodstream for long time period might have adverse cardiopulmonary effects.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009093 Mucus The viscous secretion of mucous membranes. It contains mucin, white blood cells, water, inorganic salts, and exfoliated cells.
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli
D013431 Sulfates Inorganic salts of sulfuric acid. Sulfate,Sulfates, Inorganic,Inorganic Sulfates

Related Publications

M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
May 1975, Journal of applied physiology,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
January 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
August 1975, Journal of applied physiology,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
May 1980, The American review of respiratory disease,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
June 1977, The American review of respiratory disease,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
November 1966, Journal of applied physiology,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
August 1979, The American review of respiratory disease,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
July 1979, The American review of respiratory disease,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
April 1973, Journal of applied physiology,
M A Sackner, and R L Dougherty, and G A Chapman, and J Cipley, and D Perez, and M Kwoka, and M Reinhart, and M Brito, and R Schreck
March 1981, The American review of respiratory disease,
Copied contents to your clipboard!